Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 554

1.

Hyperlipidemia following treatment with antipsychotic medications.

Olfson M, Marcus SC, Corey-Lisle P, Tuomari AV, Hines P, L'Italien GJ.

Am J Psychiatry. 2006 Oct;163(10):1821-5.

PMID:
17012695
[PubMed - indexed for MEDLINE]
2.

Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia.

Lambert BL, Chang KY, Tafesse E, Carson W.

J Clin Psychopharmacol. 2005 Feb;25(1):12-8.

PMID:
15643095
[PubMed - indexed for MEDLINE]
3.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
[PubMed - indexed for MEDLINE]
4.

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.

Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, Revicki D, Buchanan RW.

Arch Gen Psychiatry. 2002 Nov;59(11):1021-6.

PMID:
12418935
[PubMed - indexed for MEDLINE]
5.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
[PubMed - indexed for MEDLINE]
6.

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

Pharmacotherapy. 2007 Jan;27(1):27-35.

PMID:
17192159
[PubMed - indexed for MEDLINE]
7.

Somnolence effects of antipsychotic medications and the risk of unintentional injury.

Said Q, Gutterman EM, Kim MS, Firth SD, Whitehead R, Brixner D.

Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):354-64. doi: 10.1002/pds.1559.

PMID:
18314925
[PubMed - indexed for MEDLINE]
8.

[Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].

Bret P, Bonnet F, Bret MC, Jaffré A.

Encephale. 2002 Jul-Aug;28(4):329-42. French.

PMID:
12232542
[PubMed - indexed for MEDLINE]
9.

Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study.

Saari K, Koponen H, Laitinen J, Jokelainen J, Lauren L, Isohanni M, Lindeman S.

J Clin Psychiatry. 2004 Apr;65(4):547-50.

PMID:
15119919
[PubMed - indexed for MEDLINE]
10.

Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States.

Daumit GL, Crum RM, Guallar E, Powe NR, Primm AB, Steinwachs DM, Ford DE.

Arch Gen Psychiatry. 2003 Feb;60(2):121-8.

PMID:
12578429
[PubMed - indexed for MEDLINE]
11.

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.

Citrome L, Jaffe A, Levine J, Allingham B, Robinson J.

Psychiatr Serv. 2004 Sep;55(9):1006-13.

PMID:
15345760
[PubMed - indexed for MEDLINE]
12.
13.

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.

Lund BC, Perry PJ, Brooks JM, Arndt S.

Arch Gen Psychiatry. 2001 Dec;58(12):1172-6.

PMID:
11735847
[PubMed - indexed for MEDLINE]
14.

Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA.

J Clin Psychiatry. 2002 Oct;63(10):920-30.

PMID:
12416602
[PubMed - indexed for MEDLINE]
15.

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.

Gianfrancesco F, Pesa J, Wang RH, Nasrallah H.

Am J Health Syst Pharm. 2006 Mar 1;63(5):431-41.

PMID:
16484517
[PubMed - indexed for MEDLINE]
16.

[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].

Rubio G, Gómez-de-la-Cámara A, Ledesma F, Burón JA, Rodríguez-Morales A, Martínez-Junquera G; Grupo Español para el Estudio de la Diabetes en Pacientes Esquizofrénicos.

Med Clin (Barc). 2006 Apr 1;126(12):441-4. Spanish.

PMID:
16620729
[PubMed - indexed for MEDLINE]
17.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
[PubMed - indexed for MEDLINE]
18.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
[PubMed - indexed for MEDLINE]
19.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768
[PubMed - indexed for MEDLINE]
20.

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.

Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW.

Arch Gen Psychiatry. 2010 Jan;67(1):17-24. doi: 10.1001/archgenpsychiatry.2009.179.

PMID:
20048219
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk